KRTAP5-3

gene
On this page

Also known as KRTAP5.3KRTAP5-9

Summary

KRTAP5-3 (keratin associated protein 5-3, HGNC:23598) is a protein-coding gene on chromosome 11p15.5, encoding Keratin-associated protein 5-3 (Q6L8H2). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….

Predicted to be located in cytosol.

Source: NCBI Gene 387266 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 38 total
  • MANE Select transcript: NM_001012708

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23598
Approved symbolKRTAP5-3
Namekeratin associated protein 5-3
Location11p15.5
Locus typegene with protein product
StatusApproved
AliasesKRTAP5.3, KRTAP5-9
Ensembl geneENSG00000196224
Ensembl biotypeprotein_coding
Entrez387266

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000399685

RefSeq mRNA: 1 — MANE Select: NM_001012708 NM_001012708

CCDS: CCDS41591

Canonical transcript exons

ENST00000399685 — 1 exons

ExonStartEnd
ENSE0000153962116075651608463

Expression profiles

Bgee: expression breadth broad, 16 present calls, max score 40.73.

Top tissues by expression

108 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534340.73silver quality
ventricular zoneUBERON:000305340.66silver quality
skin of abdomenUBERON:000141640.35gold quality
zone of skinUBERON:000001439.13gold quality
duodenumUBERON:000211438.86silver quality
skin of legUBERON:000151138.75gold quality
apex of heartUBERON:000209838.52silver quality
granulocyteCL:000009438.13gold quality
colonic epitheliumUBERON:000039737.20gold quality
mucosa of transverse colonUBERON:000499136.31gold quality
bone marrow cellCL:000209236.16gold quality
hindlimb stylopod muscleUBERON:000425236.11gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
muscle tissueUBERON:000238532.30gold quality
bone marrowUBERON:000237131.74gold quality
sural nerveUBERON:001548830.93gold quality
prefrontal cortexUBERON:000045130.51gold quality
cortex of kidneyUBERON:000122530.39gold quality
stromal cell of endometriumCL:000225529.87gold quality
right hemisphere of cerebellumUBERON:001489029.69gold quality
leukocyteCL:000073829.03gold quality
kidneyUBERON:000211328.62gold quality
monocyteCL:000057628.50gold quality
urinary bladderUBERON:000125528.23gold quality
primary visual cortexUBERON:000243628.20gold quality
smooth muscle tissueUBERON:000113528.04gold quality
adult mammalian kidneyUBERON:000008227.98gold quality
placentaUBERON:000198727.67gold quality
olfactory segment of nasal mucosaUBERON:000538627.60gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.07

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

4 targeting KRTAP5-3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-10B-3P99.0466.98988
HSA-MIR-7114-3P98.4266.53569
HSA-MIR-3940-3P84.9061.3132

Cross-species orthologs

0 orthologs

Paralogs (1): KRTAP5-4 (ENSG00000241598)

Protein

Protein identifiers

Keratin-associated protein 5-3Q6L8H2 (reviewed: Q6L8H2)

Alternative names: Keratin-associated protein 5-9, Keratin-associated protein 5.3, Keratin-associated protein 5.9, UHS KerB-like, Ultrahigh sulfur keratin-associated protein 5.3

All UniProt accessions (1): Q6L8H2

UniProt curated annotations — full annotation on UniProt →

Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

Subunit / interactions. Interacts with hair keratins.

Tissue specificity. Restricted to hair root, not detected in any other tissues.

Similarity. Belongs to the KRTAP type 5 family.

RefSeq proteins (1): NP_001012726* (*=MANE)

Domains & families (InterPro)

UniProt features (19 total): repeat 11, sequence variant 5, chain 1, region of interest 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6L8H2-F135.550.00

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-1266738Developmental Biology

MSigDB gene sets: 40 (showing top): chr11q13, GOBP_EPIDERMIS_DEVELOPMENT, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, MODULE_112, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, MODULE_220, FIGUEROA_AML_METHYLATION_CLUSTER_6_DN, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_KERATINIZATION, JAK2_DN.V1_UP, GOCC_SUPRAMOLECULAR_POLYMER, MIR135A_3P, LOPEZ_MBD_TARGETS

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cytoplasm1
cellular anatomical structure1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

141 interactions, top by confidence:

ABTypeScore
LCE5AKRTAP5-3psi-mi:“MI:0915”(physical association)0.600
KRTAP5-3LCE5Apsi-mi:“MI:0915”(physical association)0.600
KRTAP5-3NUFIP2psi-mi:“MI:0915”(physical association)0.560
POU4F2KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3KRTAP9-3psi-mi:“MI:0915”(physical association)0.560
LCE2CKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3CATSPER1psi-mi:“MI:0915”(physical association)0.560
NOTCH2NLCKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
HOXA1KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
SMCPKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
OTX1KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3RGS17psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3KRTAP5-1psi-mi:“MI:0915”(physical association)0.560
MEOX2KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP1-3KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
CYSRT1KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3NR4A3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3ADAMTSL4psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE1DKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KPRPKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE3AKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE1CKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE3CKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE1FKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
RAMP3KRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE4AKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
LCE1AKRTAP5-3psi-mi:“MI:0915”(physical association)0.560
KRTAP5-3KRTAP1-5psi-mi:“MI:0915”(physical association)0.560
LCE1BKRTAP5-3psi-mi:“MI:0915”(physical association)0.560

BioGRID (66): KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid), KRTAP5-3 (Two-hybrid)

ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 42 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization2336.6×4e-31
Formation of the cornified envelope1332.6×4e-16

GO biological processes:

GO termPartnersFoldFDR
keratinization1290.6×3e-19

Disease & clinical

Clinical variants and AI predictions

ClinVar

38 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance33
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

733 predictions. Top by Δscore:

VariantEffectΔscore
11:1608192:C:CAdonor_gain0.9800
11:71548538:A:Tdonor_gain0.9700
11:1608189:ACCC:Adonor_gain0.9600
11:1608190:CCCC:Cdonor_gain0.9600
11:1608218:G:Cdonor_gain0.9600
11:1608060:C:CAdonor_gain0.8700
11:1608213:C:CTdonor_gain0.8700
11:1608253:CGGG:Cdonor_gain0.8200
11:1608216:CAG:Cdonor_gain0.8000
11:71548831:C:Tdonor_gain0.7800
11:71548537:G:GTdonor_gain0.7600
11:1608362:T:TAdonor_gain0.7400
11:71548517:GAGC:Gdonor_gain0.7400
11:1607968:C:CCacceptor_gain0.7300
11:1608064:TGGA:Tdonor_gain0.7300
11:1607964:CAGC:Cacceptor_gain0.7200
11:1608243:CAGCA:Cdonor_gain0.7200
11:1608345:CAG:Cdonor_gain0.7200
11:1607798:C:CCacceptor_gain0.6900
11:1608202:C:Adonor_gain0.6900
11:1608203:C:CAdonor_gain0.6900
11:1608245:G:Cdonor_gain0.6900
11:1607968:C:Aacceptor_loss0.6800
11:1608206:A:ACdonor_gain0.6800
11:1608207:C:CCdonor_gain0.6800
11:1608359:G:GAdonor_gain0.6800
11:1608273:G:Cdonor_gain0.6700
11:1607966:GC:Gacceptor_gain0.6600
11:1607967:CC:Cacceptor_gain0.6600
11:1608214:C:CTdonor_gain0.6600

AlphaMissense

1541 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:1607879:G:CS169R0.746
11:1607879:G:TS169R0.746
11:1607881:T:GS169R0.746
11:1608257:C:AK43N0.712
11:1608257:C:GK43N0.712
11:1607909:G:CS159R0.682
11:1607909:G:TS159R0.682
11:1607911:T:GS159R0.682
11:1607822:G:CS188R0.643
11:1607822:G:TS188R0.643
11:1607824:T:GS188R0.643
11:1607939:G:CS149R0.635
11:1607939:G:TS149R0.635
11:1607941:T:GS149R0.635
11:1607673:A:CI238S0.634
11:1607705:G:CS227R0.631
11:1607705:G:TS227R0.631
11:1607707:T:GS227R0.631
11:1607792:G:CS198R0.629
11:1607792:G:TS198R0.629
11:1607794:T:GS198R0.629
11:1607673:A:GI238T0.617
11:1607675:C:AK237N0.614
11:1607675:C:GK237N0.614
11:1608047:A:CF113L0.613
11:1608047:A:TF113L0.613
11:1608049:A:GF113L0.613
11:1607789:G:CC199W0.609
11:1607735:G:CS217R0.601
11:1607735:G:TS217R0.601

dbSNP variants (sampled 300 via entrez): RS1002018975 (11:1607313 G>T), RS1002081205 (11:1607133 G>A), RS1003554553 (11:1608375 G>A,C), RS1005482515 (11:1608029 C>T), RS1006046959 (11:1609559 T>C), RS1008665574 (11:1607345 C>G,T), RS1009646061 (11:1609857 A>C), RS1010769100 (11:1607325 G>A,C), RS1012563493 (11:1609631 T>C,G), RS1012782003 (11:1609779 A>G), RS1014753445 (11:1607113 A>G), RS1015564780 (11:1607662 C>G,T), RS1016504081 (11:1609360 C>A,T), RS1018594591 (11:1607578 C>G,T), RS1019080536 (11:1607346 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

1 total (human), top 1 by PubMed support.

ChemicalActions (top 5)PubMed papers
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.